How often
your patients infuse
How often
your patients infuse
How long
the self-infusions take
How much
medicine is given per infusion
How many
infusion sites your patients use
Insights from a CSL-sponsored Harris Poll survey*
*Online survey of 104 US adults with PI who have ever received IVIg (n=65), SCIg in glass vials (n=65), and/or SCIg in prefilled syringes (n=33).
Prescribe proven protection with a first and only for Ig—Hizentra Prefilled Syringes
Simple, convenient, and ready to use
†4 g directly compatible with FreedomEdge® and VersaPump®. 10 g directly compatible with Freedom60® and SCIg60®.2-4 FreedomEdge® and Freedom60® are registered trademarks of KORU Medical Systems, Inc. VersaPump® and SCIg60® are registered trademarks of EMED Technologies Corporation. CSL Behring does not recommend or endorse specific infusion pump brands.
See prefilled syringes in action
Hear a clinician’s perspective on prefilled syringes
Insights from a CSL-sponsored Harris Poll survey‡
Most SCIg prefilled syringe patients reported a favorable treatment experience1‡
‡In an online survey, at least 32 of 33 people with PI who self-infused Ig in prefilled syringes were very/somewhat satisfied with all measures mentioned.
§Defined as total time from opening package to turning on infusion pump, including Ig transfer from vial(s) or prefilled syringe(s) into pump syringes.
||Qualified respondents with PI who have used both SCIg in glass vials and SCIg in prefilled syringes (n=7).
Explore tools and information to help you tailor treatment to individual patient needs
Dosing calculatorFind support and training programs to help make Ig therapy accessible and affordable for patients
Hizentra Connect supportExplore volumes, rates, and other information to help your patients self-administer Hizentra
Administration guidance